Diabetes Mellitus and Urinary Tract Infection: Epidemiology, Pathogenesis and Proposed Studies in Animal Models

Journal of Urology

Volumn 182, Issue 6 SUPPL., 2009, Pages

  Chen, Swaine L ^a   Jackson, Sara L ^b   Boyko, Edward J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

adhesins; diabetes complications; diabetes mellitus; Escherichia coli; experimental; genomic islands; urinary tract infections

Indexed keywords

ANTIBACTERIAL ACTIVITY; ARTICLE; AUTONOMIC NEUROPATHY; BACTERIAL VIRULENCE; DIABETES MELLITUS; DISEASE MODEL; ESCHERICHIA COLI; GLUCOSE METABOLISM; GLUCOSURIA; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESEARCH PRIORITY; RISK FACTOR; URINARY TRACT INFECTION; URINE RETENTION;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 71849098966     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.07.090     Document Type: Article

References (50)

1. Boyko E.J., Fihn S.D., Scholes D., et al. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol 161 (2005) 557
2. Boyko E.J., Fihn S.D., Scholes D., et al. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care 25 (2002) 1778
3. Brown J.S., Vittinghoff E., Kanaya A.M., et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 98 (2001) 1045
4. Muller L.M., Gorter K.J., Hak E., et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41 (2005) 281
5. Shah B.R., and Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26 (2003) 510
6. Valerius N.H., Eff C., Hansen N.E., et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 211 (1982) 463
7. Hosking D.J., Bennett T., and Hampton J.R. Diabetic autonomic neuropathy. Diabetes 27 (1978) 1043
8. Geerlings SE, Stolk RP, Camps MJ et al: Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 200; 23: 744.
9. Geerlings S.E., Stolk R.P., Camps M.J., et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 23 (2000) 1737
10. Czaja C.A., Rutledge B.N., Cleary P.A., et al. Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort. J Urol 181 (2009) 1129
11. Geerlings S.E. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31 suppl. (2008) S54
12. Geerlings S.E., Brouwer E.C., Gaastra W., et al. Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria. Adv Exp Med Biol 485 (2000) 249
13. Geerlings S.E., Meiland R., van Lith E.C., et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 25 (2002) 1405
14. Meiland R., Geerlings S.E., Stolk R.P., et al. Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med 166 (2006) 2222
15. Geerlings S.E., Brouwer E.C., Van Kessel K.C., et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 30 (2000) 995
16. Truzzi J.C., Almeida F.M., Nunes E.C., et al. Residual urinary volume and urinary tract infection-when are they linked?. J Urol 180 (2008) 182
17. Rosen D.A., Hung C.S., Kline K.A., et al. Streptozocin-induced diabetic mouse model of urinary tract infection. Infect Immun 76 (2008) 4290
18. Schilling J.D., Martin S.M., Hung C.S., et al. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 100 (2003) 4203
19. Anderson G.G., Palermo J.J., Schilling J.D., et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301 (2003) 105
20. Rosen D.A., Pinkner J.S., Jones J.M., et al. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 76 (2008) 3337
21. Martinez J.J., Mulvey M.A., Schilling J.D., et al. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19 (2000) 2803
22. Justice S.S., Hung C., Theriot J.A., et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101 (2004) 1333
23. Mulvey M.A., Schilling J.D., and Hultgren S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69 (2001) 4572
24. Mysorekar I.U., and Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 103 (2006) 14170
25. Schilling J.D., Lorenz R.G., and Hultgren S.J. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70 (2002) 7042
26. Garofalo C.K., Hooton T.M., Martin S.M., et al. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun 75 (2007) 52
27. Rosen D.A., Hooton T.M., Stamm W.E., et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4 (2007) e329
28. Rasko D.A., Rosovitz M.J., Myers G.S., et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 190 (2008) 6881
29. Johnson J.R., Scheutz F., Ulleryd P., et al. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43 (2005) 3895
30. Lloyd A.L., Rasko D.A., and Mobley H.L. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189 (2007) 3532
31. Hannan T.J., Mysorekar I.U., Chen S.L., et al. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol 67 (2008) 116
32. Xie B., Zhou G., Chan S.Y., et al. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem 281 (2006) 14644
33. Sokurenko E.V., Chesnokova V., Dykhuizen D.E., et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A 95 (1998) 8922
34. Sokurenko E.V., Feldgarden M., Trintchina E., et al. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol 21 (2004) 1373
35. Ronald L.S., Yakovenko O., Yazvenko N., et al. Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 105 (2008) 10937
36. Chen SL, Hung CS, Pinkner JS et al: Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Unpublished data.
37. Wright K.J., Seed P.C., and Hultgren S.J. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 9 (2007) 2230
38. Bishop B.L., Duncan M.J., Song J., et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13 (2007) 625
39. Thumbikat P., Berry R.E., Zhou G., et al. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5 (2009) e1000415
40. Connell I., Agace W., Klemm P., et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93 (1996) 9827
41. Lane M.C., Lockatell V., Monterosso G., et al. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 73 (2005) 7644
42. Wright K.J., Seed P.C., and Hultgren S.J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 73 (2005) 7657
43. Justice S.S., Hunstad D.A., Seed P.C., et al. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 103 (2006) 19884
44. Justice S.S., Lauer S.R., Hultgren S.J., et al. Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 74 (2006) 4793
45. Hagan E.C., and Mobley H.L. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol 71 (2009) 79
46. Smith Y.C., Rasmussen S.B., Grande K.K., et al. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 76 (2008) 2978
47. Rippere-Lampe K.E., O'Brien A.D., Conran R., et al. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun 69 (2001) 3954
48. Johnson D.E., Drachenberg C., Lockatell C.V., et al. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immun Med Microbiol 28 (2000) 37
49. Lane M.C., and Mobley H.L. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 72 (2007) 19
50. Lloyd A.L., Henderson T.A., Vigil P.D., et al. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol 191 (2009) 3469